J 2018

Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction

TWERENBOLD, R.; J.T. NEUMANN; N.A. SORENSEN; F. OJEDA; M. KARAKAS et al.

Základní údaje

Originální název

Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction

Autoři

TWERENBOLD, R.; J.T. NEUMANN; N.A. SORENSEN; F. OJEDA; M. KARAKAS; J. BOEDDINGHAUS; T. NESTELBERGER; P. BADERTSCHER; M.R. GIMEENEZ; C. PUELACHER; K. WILDI; N. KOZHUHAROV; D. BREITENBUECHER; E. BISKUP; J.D. de LAVALLAZ; D. FLORES; D. WUSSLER; O. MIRO; F.J.M. SANCHEZ; B. MORAWIEC; Jiří PAŘENICA; N. GEIGY; D.I. KELLER; T. ZELLER; T. REICHLIN; S. BLANKENBERG; D. WESTERMANN a C. MUELLER

Vydání

Journal of the American College of Cardiology, New York, Elsevier Science INC, 2018, 0735-1097

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 18.639

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/18:00104902

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

diagnosis of myocardial infarction; diagnostic algorithms; myocardial infarction; rule-in; rule-out; troponin

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 18:15, Soňa Böhmová

Anotace

V originále

BACKGROUND The safety of the European Society of Cardiology (ESC) 0/1-h algorithm for rapid rule-out and rule-in of non-ST-segment elevation myocardial infarction (NSTEMI) using high-sensitivity cardiac troponin (hs-cTn) has been questioned. OBJECTIVES This study aimed to validate the diagnostic performance of the 0/1-h algorithm in a large multicenter study. METHODS The authors prospectively enrolled unsetected patients in 6 countries presenting to the emergency department with symptoms suggestive of NSTEMI. Final diagnosis was centrally adjudicated by 2 independent cardiologists. Hs-cTnT and hs-cTnI blood concentrations were measured at presentation and after 1 h. Safety of rule-out was quantified by the negative predictive value (NPV) for NSTEMI, accuracy of rule-in by the positive predictive value (PPV), and overall efficacy by the proportion of patients triaged towards rule-out or rule-in within 1 h. RESULTS Prevalence of NSTEMI was 17%. Among 4,368 patients with serial hs-cTnT measurements available, safety of rule-out (NPV 99.8%, 2,488 of 2,493), accuracy of rule-in (PPV 74.5%, 572 of 768), and overall efficacy were high by assigning three-fourths of patients either to rule-out (57%, 2,493 to 4,368) or rule-in (18%, 768 to 4,368). Similarly, among 3,500 patients with serial hs-cTnI measurements, safety of rule-out (NPV 99.7%, 1,528 of 1,533), accuracy of rule-in (PPV 62.3%, 498 of 800), and overall efficacy were high by assigning more than two-thirds of patients either to rule-out (44%, 1,533 of 3,500) or rule-in (23%, 800 of 3,500). Excellent safety was confirmed in multiple subgroup analyses including patients presenting early h) after chest pain onset. CONCLUSIONS The ESC 0/1-h algorithm using hs-cTnT and hs-cTnI is very safe and effective in triaging patients with suspected NSTEMI. (C) 2018 by the American College of Cardiology Foundation.